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Background
Bluetongue is a major disease of ruminant livestock that
can have a substantial impact on income and animal
welfare. Bluetongue virus serotype 8 (BTV-8) first
emerged in the European Union in 2006, peaking at
45,000 cases in 2008. Zoetis (formerly Pfizer Animal
Health) licensed bluetongue vaccines (Zulvac 4 Ovis,
Zulvac 1 Ovis, Zulvac 1 Bovis, Zulvac 8 Ovis and Zulvac
8 Bovis and combinations) able to prevent viremia,
stressing the role of the vaccine as an aid for the epide-
miological control of the disease.
One important issue to be taken into account in the
development of vaccines is their cost, especially in veter-
inary use. Vaccine production requires high-yield, stable
bioproduction systems and implementation of new
technologies.
Mammalian cells are the substrate for production of
most of the veterinary vaccines. BHK-21 cells are com-
monly used to produce bluetongue vaccines.
As an example, the use of the BTV-8 vaccine is routi-
nely produced in roller bottles (RB). The aim of this
study is to investigate Single-Use Bioreactor technology
as an alternative to RB. This technology combines the
basic concept of allowing the cells to attach to a surface
(microcarriers) with the advantages of suspension, which
allows a better control of culture conditions and sys-
tematic and automatic culture process.
Single use technology can also be an alternative to
conventional production methods reducing facility com-
plexity, possibility of the rapid expansion of the capacity
of the production and to avoid the cleaning process and
reduction of the risk of cross-contamination. Lower cul-
ture handling and more homogeneity can be achieved.
Selection of appropriate culture conditions can be
important to achieve consistent cell culture and virus
production across sites and scales. Because characteris-
tics like tank geometry and hardware (impellers, sparger)
are not subject to change during scale-up, the scalability
from 50L to 1000L in the BIOSTAT® STR bioreactor
can be an easy strategy for our production process.
Materials and methods
Cell line
BHK-21. These cells were used because they are permis-
sible to BTV replication. All cells were cultured at 37°C
in MEM-G medium supplemented with serum.
Virus strain
BTV-8, strain BEL2006/02, supplied by “Veterinary and
Agrochemical Research Centre” (VAR-CODA-CERVA),
Ukkel, Belgium.
Cultivation system
The growth of the BHK-21 cells and production of virus
was performed in roller bottles and 50L single-use bior-
eactor BIOSTAT® STR (Sartorius Stedim Biotech).
BHK-21 cells were grown in microcarriers Cytodex-3
at 3g/L into the STR bioreactor and the cell production
was optimized with respect to pH, temperature, stirring
speed and aeration rate.
Viable cell number was evaluated using the crystal
violet dye nucleus staining method.
Virus infection and titration
The virus chosen to compare and prove the suitability
of Single use technology for the production of viral vac-
cines was BTV-8.
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Confluent cells were infected at a constant MOI and
harvesting was done at 100% CPE.
Virus production was calculated according to the
Spearman-Kärber method, expressing the result in tissue
culture infectious doses (50%) (TCID50).
Cell growth and BTV-8 antigen production in the
BIOSTAT® STR bioreactor was conducted at the opti-
mal conditions determined previously on conventional
bioreactors.
Microcarriers elimination
Taking into account that for vaccine formulation micro-
carriers must be eliminated from the viral suspension,
filtration through Sartopure PP2 cartridges (from Sartor-
ius Stedim Biotech) was performed.
Results
The final goal is to maximize productivity preserving its
quality.
How? By increasing cell concentration and cell
productivity.
To demonstrate the feasibility of bioreactors for
microcarriers cell cultures, the growth of BHK-21 cells
in roller bottles, and in the BIOSTAT® STR bioreactor
was evaluated and compared.
Results prove that when using the 50L BIOSTAT® STR
bioreactor, BHK-21 cells are attached and grow efficiently
on microcarriers. Cell concentration yield in terms of
average was higher than in roller bottles (Figure 1).
The virus titers reached in the BIOSTAT® STR bior-
eactor were equal o higher than the levels obtained in
roller bottles (Figure1).
Conclusions
▪ Comparable results between Roller bottles and




▪ BHK-21 cells grow efficiently on microcarriers.
Conditions for cell attachment in terms of mixing
conditions were optimized.
▪ BTV-8 antigen with satisfactory yields can be
obtained by culturing BHK-21 in a 50L BIOSTAT®
STR bioreactor.
▪ As expected, high density of BHK-21 cultures
showed increased productivity
▪ Microcarrier filtration causes no significant drop
in virus titer.
▪ With the conditions established with the 50L BIO-
STAT® STR bioreactor the reproducibility and the
scale-up from 50L to 1000L can be easily performed.
▪ Single-Use Bioreactor technology is a good alter-
native to Roller Bottles and is a suitable system for
propagation of BTV-8 virus using adherent BHK
cells on microcarriers. Involving reduction of costs,
cleaning, sterilization etc.
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Figure 1 Comparison of cell growth and virus titer in roller bottles and in 50 liter BIOSTAT®CultiBagSTR single-use bioreactor
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